Diabetes mellitus (DM) increases the risk complications in addition to mortality. Quantifying the risk of complications using artificial intelligence could be a way to design comprehensive patient healthcare programs.

Predicting the probability of macro and microvascular complications in patients with DM through Machine Learning.

Retrospective cohort study. Based on an outpatient follow-up program for diabetic patients, 64,081 records and 287 variables were identified, with highly unbalanced data. Predictive models for chronic kidney disease (CKD), lower extremity amputation (LEA), coronary heart disease (CHD), and early mortality (MOR) were developed. An exhaustive computational method was conducted to find the best combination between machine learning (ML) algorithms and sampling method.

The best model was determined by assessing its performance through the heuristics obtained from a comprehensive analysis of the accuracy and F1 values for ML, sampling, and dataset. Regarding each complication, 99.9% accuracy was obtained for LEA, 94.3% for CHD, 97.4% for MOR, and 98.8% for CKD. F1 was assessed to identify false positives, with 84.5% for CKD, 63.6% for MOR, 46.2% for LEA, and 44.8% for CHD.

This ML model can be applied to predict CHD, CKD, and MOR. The success of ML predictions lies in the clinical definition of initial variables and their simplification for obtaining variables based on which the algorithms can identify patients that are likely to develop a complication. For clinical application of this system, it is necessary to assess the cross performance of metrics, as found here (accuracy higher 95% and F1-Score higher than 80%).